Debevoise Guides Allergan In $2.47B Zeltiq Buy

Allergan, led by Debevoise & Plimpton LLP, will pay $2.47 billion to pick up Zeltiq as the Ireland-based pharmaceutical giant looks to bolster its aesthetics portfolio with a company that uses...

Already a subscriber? Click here to view full article